Gebelikte Tanı Konulan Budd-Chiari Sendromu Takip ve Yönetimi – Olgu Sunumu

Year 2020, Volume: 51 Issue: 3, 165 - 167, 30.09.2020

Reyhan Ayaz , İlayda Loçlar Karaalp , Ateş Karateke

https://doi.org/10.16948/zktipb.738917

Abstract

Abstract
Budd-Chiari syndrome is a clinical disorder that causes congestive liver damage as a result of obstruction of hepatic venous blood flow. Many underlying factors cause thrombosis such as pregnancy, oral contraceptive use, myeleoproliferative diseases, antiphospholipid syndrome(aPL). Due to BCS is rarely seen in pregnancy, there are limited data , regarding pregnancy outcome and management during the pregnancy and postpartum period. In this case report, we describe a case of patients with BCS developed based on aPL during the pregnancy.
Özet
Budd-Chiari(BCS) sendromu hepatik venöz kanın kalbe ulaşım yolunda obstrüksiyonu sonucu konjesyona bağlı karaciğer hasarına sebep olan gebelikte nadir rastlanan bir klinik tablodur. Etiyolojisinde gebelik, oral kontraseptif kullanımı, myeleoproliferatif hastalıklar, antifosfolipid antikor sendromu gibi tromboza eğilim yaratan altta yatan birçok hastalık mevcuttur. BCS'li kadınlarda gebelik ve gebelik sonrası yönetim ve gebelik sonuçları hakkında yeterli veri bulunmamaktadır. Bu olgu sunumunda antifosfolipid antikor sendromu zemininde BCS gelişen gebe olgusu bildirilmiştir.

Keywords

Budd-Chiari Sendromu, Antifosfolipid Sendromu, GEBELİK

References

• Aydinli M, Bayraktar Y. Budd-Chiari syndrome: Etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007;13(19):2693–6.
• Rautou PE, Angermayr B, Garcia-Pagan JC, Moucari R, Peck-Radosavljevic M, Raffa S, et al. Pregnancy in women with known and treated Budd-Chiari syndrome: Maternal and fetal outcomes. J Hepatol. 2009;
• Khuroo MS, Datta D V. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med. 1980;
• Türk Cerrahi Derneği. Gastrointestinal Sistem Endoskopisi. 2016.
• Grus T, Lambert L, Grusová G, Banerjee R, Burgetová A. Budd-Chiari Syndrome. Prague Med Rep. 2017;
• Ren W, Li X, Jia J, Xia Y, Hu F, Xu Z. Prevalence of budd-chiari syndrome during pregnancy or puerperium: A systematic review and meta-analysis. Gastroenterol Res Pract. 2015;2015.
• Espinosa G, Font J, García-Pagan JC, Tàssies D, Reverter JC, Gaig C, et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: Clinical and immunologic characteristics of 43 patients. Medicine (Baltimore). 2001;80(6):345–54.
• Merz WM, Rüland AM, Hippe V, Poetzsch B, Meyer C, Pollok JM, et al. Pregnancy in Budd-Chiari Syndrome: Case Report and Proposed Risk Score. Medicine (Baltimore). 2016;
• Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, et al. Hepatic outflow obstruction (budd-chiari syndrome): Experience with 177 patients and a review of the literature. Med (United States). 1994;73;21-36
• Khan F, Rowe I, Martin B, Knox E, Johnston T, Elliot C, et al. Outcomes of pregnancy in patients with known Budd-Chiari syndrome. World J Hepatol. 2017;
• Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;
• Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators of Budd-Chiari syndrome: A systematic review of 79 studies. Expert Review of Gastroenterology and Hepatology. 2015.
• Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J. 1997;
• Ramsey PS, Hay JE, Ramin KD. Successful pregnancy following orthotopic liver transplantation for idiopathic budd-chiari syndrome. J Matern Neonatal Med. 1998;
• Aggarwal N, Suri V, Chopra S, Sikka P, Dhiman RK, Chawla YK. Pregnancy outcome in Budd Chiari Syndrome-a tertiary care centre experience. Arch Gynecol Obstet. 2013;
• Segal S, Shenhav S, Segal O, Zohav E, Gemer O. Budd-Chiari syndrome complicating severe preeclampsia in a parturient with primary antiphospholipid syndrome. Eur J Obstet Gynecol Reprod Biol. 1996;
• Pati S, Bhattacharya S, Rakshit VM. Pregnancy complicated by Budd-Chiari syndrome and antiphospholipid syndrome. J Obstet Gynaecol (Lahore). 2009;29;145-146
• Joffe GM, Aisenbrey GA, Argubright KF. Budd-chiari syndrome, systemic lupus erythematosus, and secondary antiphospholipid antibody syndrome in pregnancy. Obstet Gynecol. 2005;
• Polzin WJ, Kopelman JN, Robinson RD, Read JA, Brady K. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol. 1991;
• Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4;295-306